Search

everythinglearnresearchcommunity

for

Search:↓

The HOXC13 gene affects different hair proteins in cashmere goats in varied ways and is controlled by a feedback loop and other factors.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Methamphetamine affects gene expression in rat whisker follicles, with key genes linked to addiction.

ADAM 10 and ADAM 12 proteins are involved in different stages of hair growth and could be targets for treating hair disorders.

The peach gene pCTG134 helps control the interaction between auxin and ethylene hormones during fruit ripening.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Cells from certain embryo parts can induce head formation in another embryo, involving complex signaling pathways.

Hair follicles in the back of the rosette fancy mouse have reversed orientations due to a gene mutation.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.